可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Isner J, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization[J]. J Clin Invest, 1999, 103(9):1231-1236.
[2] Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential endothelial progenitor cells for of ex vivo expanded myocardial ischemia[J]. Circulation, 2001, 103(5):634-637.
[3] Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans[J]. Circulation, 2002, 106(15):1913-1918.
[4] Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure[J]. Circulation, 2003, 107(18):2294-2302.
[5] Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronaryartery disease: a feasibility study[J]. J Am Coll Cardiol, 2003, 41(10):1721-1724.
[6] Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages[J]. J Thorac Cardiovasc Surg, 2000, 120(5):999-1005.
[7] Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart[J]. Circulation, 2002, 105(1):93-98.
[8] Davani S, Marandin A, Mersin N, et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model[J]. Circulation, 2003, 108(Suppl 1):II253-II258.
[9] Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium[J]. Nature, 2001 ,410(6829):701-705.
[10]Verma S, Kuliszewski MA, Li SH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation and function[J]. Circulation, 2004, 109(7):2058-2067.